Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

A joint application of disease risk score and propensity score to control for confounding: A clinical example

Conference paper

Ali MS. et al, (2018), Pharmacoepidemiology and drug safety, 27, 27 - 27

Deep learning to detect features of a population of anti-osteoporosis drug users

Conference paper

Khalid S. et al, (2018), Pharmacoepidemiology and drug safety, 27, 345 - 346

Evaluation of treatment effect modification in propensity score matching: An empirical example

Conference paper

Ali MS. et al, (2018), Pharmacoepidemiology and drug safety, 27, 25 - 25

Impact of risk minimisation measures on the use of strontium ranelate: A multinational cohort study in 5 EU countries by the EU-ADR Alliance

Conference paper

Berencsi K. et al, (2018), Pharmacoepidemiology and drug safety, 27, 189 - 189

Oral bisphosphonate use and latent class trajectories of kidney function: A cohort study

Conference paper

Strauss VY. et al, (2018), Pharmacoepidemiology and drug safety, 27, 186 - 186

Self-medication practices and associated factors among undergraduate medical students in St Paul Hospital Millennium Medical College

Conference paper

Ethiopia S. et al, (2018), Pharmacoepidemiology and drug safety, 27, 444 - 444

Cluster Analysis to Detect Patterns of Drug Use from Routinely Collected Medical Data

Conference paper

Khalid S. et al, (2018), Proceedings - ieee symposium on computer-based medical systems, 2018-June, 194 - 198

One and two-year persistence with different anti-osteoporosis medications: a retrospective cohort study.

Journal article

Reyes C. et al, (2017), Osteoporos int, 28, 2997 - 3004

Impact of Risk Minimisation Measures on the Use of Strontium Ranelate: A Multi-National Cohort Study in 5 EU Countries by the EU-ADR Alliance

Conference paper

Berencsi K. et al, (2017), Pharmacoepidemiology and drug safety, 26, 483 - 483

Instrumental Variables to Test for Unmeasured Confounding: A Precautionary Note

Conference paper

Ali MS. et al, (2017), Pharmacoepidemiology and drug safety, 26, 230 - 231

Sub-Groups of Anti-Osteoporosis Drug Users, and Associated Fracture Risk in Real World Primary Care Settings: A Data-Driven Cluster Analysis

Conference paper

Khalid S. et al, (2017), Pharmacoepidemiology and drug safety, 26, 327 - 327

Load More